Hims & Hers Greenlights Fresh $250M Stock Buyback Initiative Over Three-Year Horizon

2025-12-26 03:45:42

Hims & Hers Health, Inc. (HIMS) has taken another step to unlock shareholder value, with its board greenlighting a substantial $250 million repurchase initiative for Class A common stock spanning the next three years. This move signals management confidence in the company’s prospects and its assessment that current share valuations may underestimate the business’s underlying fundamentals.

The buyback authorization comes on the heels of the company fully deploying its previous $100 million repurchase plan, which launched in July 2024. The succession of buyback programs underscores the health and wellness platform’s commitment to capital allocation strategies aimed at enhancing shareholder returns.

Market participants took notice, with Hims & Hers Health shares climbing 0.11% in early trading to reach $36.98 on the New York Stock Exchange. The stock movement reflects investor sentiment regarding the strategic deployment of capital and management’s conviction about the company’s valuation relative to its earning potential and competitive positioning in the telehealth and digital health sector.

The repurchase program demonstrates how the company intends to balance growth investments with returning cash to shareholders, a move increasingly common among profitable tech-enabled healthcare platforms seeking to reward existing stakeholders while maintaining operational flexibility for future opportunities.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.